Haemophiliacs are a group of multitransfused individuals often requiring weekly infusions of factor VIII, either to treat bleeding episodes or as part of a prophylactic regimen. Cryoprecipitate is still the mainstay of therapy in the United Kingdom, although Iyophilised factor VIII concentrates are being used increasingly.
Hepatitis in patients receiving whole blood has been well documented (Wallace, 1976) . While clinical hepatitis after transfusion of blood products is uncommon in haemophiliacs (Lewis, 1970; Biggs, 1974) , several reports have appeared in the literature documenting the presence of persistent abnormalities of liver function tests in the majority of these patients (Mannucci et al., 1975; Hasiba et al., 1977; Hilgartner and Giardina, 1977; Levine et al., 1977; McVerry et al., 1977; Sultan et al., 1977; Webster et al., 1977; Yannitsiotis et al., 1977) . These studies suggest that abnormal liver function tests:
(1) are present in over 50% of patients; (2) are not associated with symptomatic evidence of liver disease;
'Present address: Department of Haematology, University College Hospital, London Received for publication 22 August 1978 (3) are not related to the intensity of factor VIII or IX replacement therapy, the age of the patient, or the underlying nature of the haemostatic defect, ie, haemophilia, Christmas disease, or von Willebrand's disease (Hilgartner and Giardina, 1977) ; and (4) tend to persist over at least a one-year period. One study suggested that abnormal liver function was more frequent in patients receiving lyophilised factor concentrates than in those receiving cryoprecipitate (Hasiba et al., 1977) , but this has not been found by others (Levine et al., 1977; McVerry et al., 1977) .
The aetiology and long-term significance of these findings are unknown. While investigators are obviously reluctant to perform liver biopsies, a recent study gives cause for some concern . Liver biopsies were performed on six haemophiliacs who had abnormal liver function tests persisting for at least six months. Three patients had chronic active hepatitis and three chronic persistent hepatitis. These findings have since been confirmed (Spero et al., 1978 (Aledort, 1977) .
Other related observations include the high incidence of splenomegaly (Levine et al., 1977) and circulating immune complexes in haemophiliacs.
It has been suggested that these findings may be related to an infective agent or agents transmitted by blood or blood products. In support of this, significantly higher titres to cytomegalovirus have been found in haemophiliacs than in controls (Levine et al., 1977) . Whether (Bradstreet and Taylor, 1962) Percentages are given in parentheses.
OTHER VIRUSES AND MYCOPLASMA PNEUMONIAE
The incidence of antibodies detected is shown in Table 2 . These values are within the normal range for the general population, and titres were generally low (1:8 to 1:64). Anti-HAV was present in 46% of patients; the prevalence did not increase with advancing age. (Wallace, 1976) , while others appear to be infected with as yet unidentified organisms, that is, hepatitis non-A, non-B (Alter et al., 1978) . Haemophiliacs are an unusual group of patients in that they may be repeatedly exposed to blood- (60) 21 (70) 23 (77) 27 ( borne viruses and therefore may be at greater risk of developing chronic hepatitis. Fifty per cent of our patients had abnormal liver function tests, but without biopsy evidence it is not possible to determine the severity of the underlying pathological process.
With the exception of HBsAg and probably CMV, this study does not suggest that these patients are at greater risk of exposure to the viruses studied than the general population. The very high incidence of anti-HBs in our population is similar to that found by others (Peterson et al., 1973 (Spero et al., 1978) . This suggests that in those patients either virus or viral products were present in the liver and may have been related to the development of chronic progressive liver disease.
However, in that series 1 l % of patients were persistent carriers of HBsAg. This is a much higher carrier rate when compared to the haemophiliac population in this country.
The overall exposure rate to CMV was higher than normal, and CMV antibody was detected in over 90% of patients more than 40 years of age. This is particularly high when compared to the normal adult population in this country (Stern, 1972) . Most of these patients had received whole blood transfusions in the past and this is the most likely source of infection. It is interesting that patients with no evidence of previous exposure to CMV, EBV, and HBsAg rarely had abnormal liver function. The significance of this finding is at present unknown. The incidence of antibodies detected to hepatitis A was similar to that found in a small number of sera from the general population. However, hepatitis A is probably a very rare cause of post-transfusion hepatitis (Dienstag et al., 1977) .
While raised antibody titres to measles and rubella viruses have been reported previously in patients with chronic hepatitis (Triger et al., 1972; Laitinen and Vaheri, 1974) , titres were generally low (less than 1 :64) in our patients.
The long-term significance of abnormal liver function tests in these patients is unclear. In those patients with persistently high transaminase levels, a liver biopsy may be indicated in order to obtain a pathological diagnosis. Whether those patients with chronic active hepatitis should be given specific therapy, for example, corticosteroids, will be a matter for consideration. In non-haemophiliacs, persistently abnormal liver function tests have been reported after an episode of non-A, non-B posttransfusion hepatitis, and liver biopsies showed chronic active hepatitis (Knodell et al., 1977) . Such viruses have been incriminated as causing acute hepatitis in haemophiliacs after factor VIII replacement therapy (Craske et al., 1978) . The relationship of the non-A, non-B hepatitis virus or viruses to chronic asymptomatic liver disease in haemophiliacs is unknown. The recent demonstration of the ability to transfer this -gent(s) from human sera to animals (Alter et al., 1978; Tabor et al., 1978) , and the development of an immunoassay (Prince, 1978) , are promising tools for research into this particular problem. 
